J2930 HCPCS code: Injection, methylprednisolone sodium succinate, up to 125 mg
J2930 is the HCPCS Level II code for injection, methylprednisolone sodium succinate, up to 125 mg. CMS terminated J2930 on 2024-03-31; do not bill it for later dates of service. In 2024 Medicare paid an average of $3.91 per service for J2930 across 66,846 services. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. Medicare volume fell 76% from 2022 to 2024 (283,607 to 66,846 services). In 2023, 8 suppliers billed Medicare for J2930 (purchases), serving 39 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1984-01-01 |
| Last action effective | 2024-04-01 |
| Terminated | 2024-03-31 |
Who bills J2930 (2023)
| Measure | Value |
|---|---|
| Suppliers billing rentals | — |
| Suppliers billing purchases | 8 |
| Referring clinicians | 18 |
| Medicare beneficiaries | 39 |
| States with claims | 1 |
| Year | Suppliers | Beneficiaries |
|---|---|---|
| 2022 | 16 | 65 |
| 2023 | 8 | 39 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J2930, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 283,607 | 106,665 | $5.66 | $4.30 |
| 2023 | 273,307 | 103,816 | $5.37 | $4.07 |
| 2024 | 66,846 | 33,741 | $5.69 | $3.91 |
States with the most J2930 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 9,260 | $3.94 |
| Texas | 6,180 | $3.80 |
| Illinois | 5,116 | $4.31 |
| California | 4,832 | $4.01 |
| North Carolina | 3,534 | $3.78 |
What changed for J2930
- 1984-01-01: J2930 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2930?
J2930 is the HCPCS Level II code for injection, methylprednisolone sodium succinate, up to 125 mg. Short descriptor: "Methylprednisolone injection".
How much does Medicare pay for J2930?
In 2024, the average Medicare payment was $3.91 per service (average allowed $5.69).
Does Medicare cover J2930?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
Related J29 codes
- J2910 — Injection, aurothioglucose, up to 50 mg
- J2916 — Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg
- J2919 — Injection, methylprednisolone sodium succinate, 5 mg
- J2920 — Injection, methylprednisolone sodium succinate, up to 40 mg
- J2940 — Injection, somatrem, 1 mg
- J2941 — Injection, somatropin, 1 mg
- J2950 — Injection, promazine hcl, up to 25 mg
- J2993 — Injection, reteplase, 18.1 mg
- J2995 — Injection, streptokinase, per 250,000 iu
- J2997 — Injection, alteplase recombinant, 1 mg
- J2998 — Injection, plasminogen, human-tvmh, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2930
- Watch J2930 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2930
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.